is on a mission to simplify robotic-assisted surgery (RAS), so more patients and their surgeons can access its benefits every day.
Headquartered in Lincoln, Nebraska, and holding over 200 patents and patent applications, the company is developing MIRA, the first-of-its-kind miniature, and highly accessible RAS platform. With MIRA, our goal is to make every operating room RAS-ready.
MIRA is currently in FDA clinical trials under an Investigational Device Exemption (IDE) and is being studied first for bowel resection, with additional potential applications to follow.
Virtual Incision was founded by Shane Farritor, PhD, MS, and Dmitry Oleynikov, MD, FACS, who combined their NASA engineering and minimally invasive surgery (MIS) experience to create MIRA, a small, sleek RAS platform that brings a whole lot to the table.